SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-041539
Filing Date
2021-03-25
Accepted
2021-03-25 16:32:43
Documents
2
Period of Report
2021-03-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2110920-4_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2110920-4_3seq1.xml 3 1588
2 POWER OF ATTORNEY tm2110920d4_ex24-1.htm EX-24.1 7226
  Complete submission text file 0001104659-21-041539.txt   10353
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142
Business Address
Nicaise Claude (Reporting) CIK: 0001644162 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38807 | Film No.: 21772817